Digestive Diseases and Sciences

, Volume 55, Issue 10, pp 2805–2813 | Cite as

Granulocyte Colony-Stimulating Factor Enhances Bone Marrow Mononuclear Cell Homing to the Liver in a Mouse Model of Acute Hepatic Injury

  • Shi-Zhu Jin
  • Xiang-Wei Meng
  • Xun Sun
  • Ming-Zi Han
  • Bing-Rong Liu
  • Xin-Hong Wang
  • Li-Ying Sun
  • Qi Huang
  • Rui-Bo Zhao
  • Xiang Ban
  • Hong-Ying Yu
  • Hong-Wei Yu
Original Article

Abstract

Background

Experiments have reported that granulocyte colony stimulating factor (G-CSF) can mobilize stem cells. However, few studies have examined the effect of G-CSF on bone marrow mononuclear cell (BMMC) mobilization, in particular regarding their capability to home to acutely injured liver.

Aims

The aim of this study was to evaluate the effort of G-CSF on BMMC homing to the liver following chemically-induced hepatic failure.

Methods

BMMC were isolated from mice, pre-labeled with PKH26 and infused into the mice in which hepatic injury had been induced followed by administration of G-CSF or vehicle. Livers were studied by fluorescent microscopy after transplantation of pre-labeled BMMC.

Results

PKH26 labeled cells were found in liver tissue at 102 ± 10 cells/high power field in the BMMC+G-CSF group and 30 ± 5 cells/high power field in the BMMC group, but none in the G-CSF group and the control group (P < 0.05). In the former two groups the majority of PKH26 labeled cells colocalized with proliferative cell nuclear antigen (PCNA). The number of PCNA positive cells in the BMMC+G-CSF group was 20 ± 4 cells/high power field, while in the BMMC group it was 14 ± 2 cells/high power field, in the G-CSF group 12 ± 2 cells/high power field, and 8 ± 1 cells/high power field in the control group. Moreover, albumin expression was increased in the BMMC+G-CSF treated group (149 ± 7/high power field) relative to the BMMC group (48 ± 6/high power field), the G-CSF group (44 ± 5/high power field) and the vehicle group (30 ± 6/high power field), with the former three groups showing elevated levels as compared to vehicle control (30 ± 6) (P < 0.05).

Conclusion

Transplanted BMMC may home to injured liver, which appears to be enhanced by G-CSF administration.

Keywords

Granulocyte colony stimulating factor Bone marrow mononuclear cell Acute liver failure Transplantation Mobilization Autologous 

References

  1. 1.
    Masson S, Harrison DJ, Plevris JN, et al. Potential of hematopoietic stem cell therapy in hepatology: a critical review. Stem Cells. 2004;22:897–907.CrossRefPubMedGoogle Scholar
  2. 2.
    Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33:108–119.CrossRefPubMedGoogle Scholar
  3. 3.
    Thorgeirsson SS, Grisham JW. Overview of recent experimental studies on liver stem cells. Semin Liver Dis. 2003;23:303–312.CrossRefPubMedGoogle Scholar
  4. 4.
    Tarella C, Zallio F, Caracciolo D, et al. Hemopoietic progenitor cell mobilization and harvest following an intensive chemotherapy debulking in indolent lymphoma patients. Stem Cells. 1999;17:55–61.CrossRefPubMedGoogle Scholar
  5. 5.
    Di Campli C, Piscaglia AC, Giuliante F, et al. No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure. Transplant Proc. 2005;37:2563–2566.CrossRefPubMedGoogle Scholar
  6. 6.
    Gaia S, Smedile A, Omede P, et al. Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol. 2006;45:13–19.CrossRefPubMedGoogle Scholar
  7. 7.
    Fukuhara S, Tomita S, Nakatani T, et al. G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant. 2004;13:741–748.CrossRefPubMedGoogle Scholar
  8. 8.
    in ‘t Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003;88:845–852.PubMedGoogle Scholar
  9. 9.
    Jin SZ, Meng XW, Han MZ, et al. Stromal cell derived factor-1 enhances bone marrow mononuclear cell migration in mice with acute liver failure. World J Gastroenterol. 2009;15:2657–2664.CrossRefPubMedGoogle Scholar
  10. 10.
    Petersen BE, Zajac VF, Michalopoulos GK. Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats. Hepatology. 1998;27:1030–1038.CrossRefPubMedGoogle Scholar
  11. 11.
    Sheikh AY, Lin SA, Cao F, et al. Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells. 2007;25:2677–2684.CrossRefPubMedGoogle Scholar
  12. 12.
    Okada S, Nakauchi H, Nagayoshi K, et al. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood. 1992;80:3044–3050.PubMedGoogle Scholar
  13. 13.
    Perin EC, Dohmann HF, Borojevic R, et al. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Circulation. 2004;110:II213–II218.CrossRefPubMedGoogle Scholar
  14. 14.
    Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–1918.CrossRefPubMedGoogle Scholar
  15. 15.
    Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–148.CrossRefPubMedGoogle Scholar
  16. 16.
    Maga G, Hubscher U. Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci. 2003;116:3051–3060.CrossRefPubMedGoogle Scholar
  17. 17.
    Grompe M. The role of bone marrow stem cells in liver regeneration. Semin Liver Dis. 2003;23:363–372.CrossRefPubMedGoogle Scholar
  18. 18.
    Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56:947–958.PubMedGoogle Scholar
  19. 19.
    Dekker A, Bulley S, Beyene J, et al. Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol. 2006;24:5207–5215.CrossRefPubMedGoogle Scholar
  20. 20.
    Romanienko PJ, Camerini-Otero RD. Cloning, characterization, and localization of mouse and human SPO11. Genomics. 1999;61:156–169.CrossRefPubMedGoogle Scholar
  21. 21.
    Wexler SA, Donaldson C, Denning-Kendall P, et al. Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. Br J Haematol. 2003;121:368–374.CrossRefPubMedGoogle Scholar
  22. 22.
    Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430–436.CrossRefPubMedGoogle Scholar
  23. 23.
    Sugano Y, Anzai T, Yoshikawa T, et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res. 2005;65:446–456.CrossRefPubMedGoogle Scholar
  24. 24.
    Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106:1901–1910.CrossRefPubMedGoogle Scholar
  25. 25.
    Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635–638.CrossRefPubMedGoogle Scholar
  26. 26.
    Gazitt Y, Akay C. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Stem Cells. 2004;22:65–73.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Shi-Zhu Jin
    • 1
  • Xiang-Wei Meng
    • 1
  • Xun Sun
    • 2
  • Ming-Zi Han
    • 3
  • Bing-Rong Liu
    • 3
  • Xin-Hong Wang
    • 1
  • Li-Ying Sun
    • 3
  • Qi Huang
    • 4
  • Rui-Bo Zhao
    • 4
  • Xiang Ban
    • 4
  • Hong-Ying Yu
    • 3
  • Hong-Wei Yu
    • 5
  1. 1.Department of Gastroenterology, First HospitalJilin UniversityChangchunChina
  2. 2.Department of Pathology, First HospitalJilin UniversityChangchunChina
  3. 3.Department of Gastroenterology and Hepatology, Second Affiliated HospitalHarbin Medical UniversityHarbinChina
  4. 4.Teaching Experiment Center of MorphologyHarbin Medical UniversityHarbinChina
  5. 5.Department of Histology and EmbryologyHarbin Medical UniversityHarbinChina

Personalised recommendations